Jo Jewell Announces Novartis Foundation and Novo Nordisk Collaboration
Jo Jewell, Director, Head of Social Responsibility Partnerships at Novo Nordisk, shared on LinkedIn:
”We’re excited to see the Novartis Foundation and Novo Nordisk join forces to tackle cardiometabolic risk in cities.
Our new collaboration will combine insights and proven approaches from the two leading urban health programmes CARDIO 4 Cities (Novartis Foundation and Cities for Better Health (Novo Nordisk).
Initially launching in two European capitals, the goal is to build scalable models using practical tools, real-time data and catalytic funding to scale prevention and strengthen health systems in many more cities.
By working together, our collaboration has the potential to create lasting impact on urban health and social inequities.
Learn more:
Stay updated with Hemostasis Today.
-
Aug 14, 2026, 17:30Richard Habis: Hemophilia Does Not Only Affect the Child
-
Aug 14, 2026, 17:00Zahra Safarzadeh: The Critical Role of the Laboratory in Hemophilia Care
-
Aug 14, 2026, 16:39Yuriy Prokopenko: Advancing Hemostasis Through Scientific Collaboration
-
Aug 14, 2026, 16:26Antonio Paul: The Best Transfusion Is the One That Isn’t Needed
-
Aug 14, 2026, 16:24Thirunavukkarasu Angappan: What mRNA Manufacturing Teaches Us About Scaling Hemophilia Gene Therapy
-
Aug 14, 2026, 16:16Priyanka Raheja: Advancing Multidisciplinary Care for Women with Bleeding Disorders
-
Aug 14, 2026, 16:09Cristina Chang: Hemophilia B Gene Therapy BBM-H901 Approved in Macao
-
Aug 14, 2026, 16:03Muhammad Shaheer Bin Faheem: The Growing Mortality Divide in Thromboembolism and Hypertension
-
Aug 14, 2026, 15:53Peter Jaworski: Plasma Donation Myths and Why Plasma Matters